000 01319 a2200349 4500
005 20250515172148.0
264 0 _c20090930
008 200909s 0 0 eng d
022 _a1879-0402
024 7 _a10.1016/j.cbpa.2009.04.616
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPetrosino, Stefania
245 0 0 _aEndocannabinoid chemical biology: a tool for the development of novel therapies.
_h[electronic resource]
260 _bCurrent opinion in chemical biology
_cJun 2009
300 _a309-20 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAmidohydrolases
_xantagonists & inhibitors
650 0 4 _aAnimals
650 0 4 _aCannabinoid Receptor Agonists
650 0 4 _aCannabinoid Receptor Antagonists
650 0 4 _aCannabinoid Receptor Modulators
_xchemistry
650 0 4 _aChemistry, Pharmaceutical
650 0 4 _aDrug Discovery
650 0 4 _aEndocannabinoids
650 0 4 _aHumans
650 0 4 _aLipoprotein Lipase
_xantagonists & inhibitors
650 0 4 _aMonoacylglycerol Lipases
_xantagonists & inhibitors
700 1 _aLigresti, Alessia
700 1 _aDi Marzo, Vincenzo
773 0 _tCurrent opinion in chemical biology
_gvol. 13
_gno. 3
_gp. 309-20
856 4 0 _uhttps://doi.org/10.1016/j.cbpa.2009.04.616
_zAvailable from publisher's website
999 _c18884022
_d18884022